NORTH WALES, Pa. Teva Pharmaceuticals has introduced a generic version of a drug for genital herpes, shingles and cold sores, the company said Monday.
Teva announced the introduction of valacyclovir hydrochloride tablets in the 500-mg and 1-g strengths. The drug is a generic version of GlaxoSmithKline’s Valtrex.
Valtrex in those two strengths had sales of around $1.8 billion during the 12-month period ended in March 2010, according to IMS Health.
Watson Pharmaceuticals also announced Monday the introduction of its own version of the drug, also in the 500-mg and 1-g strengths.